SMAD2 and osteoporosis: Interestingly, the expression of PARD6A and p-SMAD2, two genes enriched in the TGF-beta receptor signaling pathway, were significantly decreased in DEX-induced osteoporosis cells compared with that in control cells (Fig. 4C-4 F).